A case report of papilla Vater carcinoma showing positive expression of thymidine phosphorylase

Hepato-Gastroenterology

Volumn 51, Issue 56, 2004, Pages 375-377

  Osada, Shinji ^a   Saji, Shigetoyo ^a   Takahashi, Takao ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Anomalous arrangement of the pancreaticobiliary duct; Immunochemical stain; Papilla Vater carcinoma; Thymidine phosphorylase

Indexed keywords

PROTEIN P53; THYMIDINE PHOSPHORYLASE;

ADENOCARCINOMA; ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; VATER PAPILLA CARCINOMA;

ADENOCARCINOMA; AMPULLA OF VATER; BILE DUCTS, EXTRAHEPATIC; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PANCREATIC DUCTS; PANCREATICODUODENECTOMY; THYMIDINE PHOSPHORYLASE;

EID: 1842587952     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Yamauchi S, Koga A, Matsumoto S, Tanaka M, Nakayama F: Anomalous junction of pancreatic biliary duct without congenital cyst: a possible risk factor for gall bladder cancer. Am J Gastroenterol 1987; 82:20-24.
2. Wang HP, Wu MS, Lin CC, et al: Pancreaticobiliary diseases associated with anomalous pancreaticobiliary ductal union. Gastrointest Endosc 1998; 48:184-189.
3. Suda K, Miyano T, Komura I, Matsumoto M: An abnormal pancreaticocholedocho-ductal junction in cases of biliary tract carcinoma. Cancer 1983; 52:2086-2088.
4. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikawa T, Toshitsuka H: Reparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 1996; 19:1407-1411.
5. Tanaka M, Ikeda S, Kawakami K, Nakayama F: The presence of a positive pressure gradient from pancreatic duct to choledochal cyst demonstrated by duodenoscopic microtransductal manometry; due to pancreaticobiliary reflux. Endoscopy 1982; 14:45-47.
6. Osuchi Y, Okada A, Nakamura T, et al: Histopathologic studies of congenital dilatation of the bile duct as related to an anomalous junction of the pancreaticobiliary ductal system: clinical and experimented studies. Surgery 1988; 103:168-173.
7. Levine AJ: p53, the cellular gate keeper for growth and division. Cell 1997; 88:323-331.
8. Haraguchi M, Miyadera K, Uemura K, et al: Angiogenic activity of enzyme. Nature 1994; 368:198.
9. Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH: Purification and properties of an endothelial cell growth factor from human platelets. J Bil Chem 1987; 262:4098-4103.
10. Ishikawa F, Miyazono K, Hellmann U, et al: Identification of angiogenic activity, the cloning and expression of platelet-derived endothelial cell growth factors. Nature 1989; 338:557-562.
11. Takao S, Takebayashi Y, Che X, et al: Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin Cancer Res 1998; 4:1619-1624.
12. Mizutani Y, Okada Y, Yoshida O: Expression of platelet-derived endothelial cell growth factor in bladder carcinoma. Cancer 1997; 79:1190-1194.
13. Zhao B, Kimura W, Futakawa N, et al: Significance of thymidine phospholase/platelet-derived endothelial cell growth factor in carcinoma of the papilla of vater. Jpn J Cancer Res 2000; 91:331-336.